Caribou Biosciences, Inc. (CRBU)
NASDAQ · Healthcare
Caribou Biosciences, Inc. Income Statement 2019–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | |
|---|---|---|---|---|---|---|---|
| Revenues | |||||||
| Revenue | 11.2M | 10.0M | 34.5M | 13.9M | 9.6M | 12.4M | 5.8M |
| Gross Profit | — | — | — | — | — | — | — |
| Profitability | |||||||
| Operating Income | -148.3M | -166.6M | -116.1M | -106.4M | -67.0M | -36.1M | -34.3M |
| EBITDA | -144.7M | -162.7M | -112.5M | -104.8M | -66.0M | -35.2M | -33.6M |
| Net Income | -148.1M | -149.1M | -102.1M | -99.4M | -66.9M | -34.3M | -23.4M |
| Per Share Data | |||||||
| EPS (diluted) | — | — | — | — | — | — | — |
| Shares Outstanding (dil.) | 93M | 90M | 74M | 61M | 32M | 10M | — |
Caribou Biosciences, Inc. Income Statement — FAQ
Caribou Biosciences, Inc. (CRBU) income statement over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CRBU's income statement history?
The chart and table above show Caribou Biosciences, Inc.'s income statement by year and by quarter, including the growth rate.